NCT02051322

Brief Summary

Comparison between three modalities of nebulization.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
6

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2014

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2014

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

January 29, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 31, 2014

Completed
1 day until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2014

Completed
Last Updated

January 31, 2014

Status Verified

January 1, 2014

Enrollment Period

1 month

First QC Date

January 29, 2014

Last Update Submit

January 30, 2014

Conditions

Outcome Measures

Primary Outcomes (1)

  • Lung deposition by urinary measure

    10 minutes

Study Arms (3)

Jet Nebulizer

EXPERIMENTAL

Nebulization with a jet nebulizer and a classic mask

Device: Jet Nebulizer

Trunk Mask Nebulizer

EXPERIMENTAL

Nebulization with a je nebulizer and a trunk mask

Device: Trunk Mask Nebulizer

Aerobika Nebulizer

EXPERIMENTAL

Nebulization with an Aerobika

Device: Aerobika Nebulizer

Interventions

Jet Nebulizer
Trunk Mask Nebulizer
Aerobika Nebulizer

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy Subjects

You may not qualify if:

  • Pulmonary disease
  • Cardiac disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cliniques universitaires Saint-Luc

Brussels, 1200, Belgium

RECRUITING

Central Study Contacts

Gregory Reychler, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 29, 2014

First Posted

January 31, 2014

Study Start

January 1, 2014

Primary Completion

February 1, 2014

Study Completion

February 1, 2014

Last Updated

January 31, 2014

Record last verified: 2014-01

Locations